2 not yet recruiting, 1 completed, 1 recruiting. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Not yet recruiting 2, Completed 1, Recruiting 1 |
Follow Basic Science: new trials by email Literature Review of Basic Science trials Research Report on Basic Science
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Bioequivalence of RAY1225 Injection in Healthy Participants RAY1225 - Basic Science | Phase 1 | Not yet recruiting | Guangdong Raynovent Biotech Co., Ltd | 68 | 2026-09-21 | 2026-09-18 |
| A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese Participants 14C-RAY1225 - Basic Science | Phase 1 | Not yet recruiting | Guangdong Raynovent Biotech Co., Ltd | 8 | 2026-03-15 | 2026-03-10 |
| A Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy Participants Placebo, Olpasiran, Moxifloxacin - Basic Science | Phase 1 | Completed | Amgen | 32 | 2024-09-12 | 2026-10-23 |
| The Neurobiological Effect of 5-HT2AR Modulation Psilocybine, Ketanserin - Basic Science | Phase 1 | Recruiting | Gitte Moos Knudsen | 200 | 2017-03-03 | 2024-12-16 |
Ketanserin (1) · Moxifloxacin (1) · Psilocybin (1) · olpasiran (1)
Guangdong Raynovent Biotech Co., Ltd (2) · Amgen (1) · Gitte Moos Knudsen (1)
China (1) · Denmark (1) · United Kingdom (1)
Gitte M Knudsen, Professor (1)